GlassScriptPhysician profile
Patricia Kimie Ichimura
NPI 1821064254
$11,480.16
in general payments reported to CMS, 2019-2025
16 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,193 · 2020: $167 · 2021: $824 · 2022: $546 · 2023: $5,012 · 2024: $580 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,685 · Food and Beverage: $2,977 · Entertainment: $88.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,684.56 |
| Food and Beverage | $2,977.13 |
| Entertainment | $88.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,474.45 | 2019-2025 | Dailies Aqua Comfort Plus, Dailies Total1 Multifocal, Air Optix |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $3,094.86 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $1,260.56 | 2022-2025 | Infuse, Biotrue One Day, Infuse Multifocal |
| Abbvie INC. | $326.95 | 2022-2023 | |
| Coopervision INC. | $323.37 | 2019-2025 | Myday Contact Lens |
| Dompe US, INC. | $243.06 | 2024-2025 | Oxervate |
| Lombart Brothers, INC. | $141.19 | 2025 | Opd-III |
| Johnson & Johnson Vision Care, INC. | $128.95 | 2019-2023 | Acuvue |
| Shire North American Group INC | $117.67 | 2019 | |
| Optos, INC. | $88.12 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $86.45 | 2020-2022 | |
| Hoffmann-La Roche Limited | $81.64 | 2019 | |
| Sun Pharmaceutical Industries INC. | $41.30 | 2023 | Cequa |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $15.55 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Ichimura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.